BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9487314)

  • 1. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].
    MMW Fortschr Med; 2003 Aug; 145(33-34):55. PubMed ID: 14526577
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of H. pylori eradication.
    Roesch W
    J Physiol Pharmacol; 1996 Mar; 47(1):71-7. PubMed ID: 8777309
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of H. pylori infection: the reality.
    Vakil N
    Yale J Biol Med; 1998; 71(2):119-24. PubMed ID: 10378357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cost-benefit analysis of conservative therapy of gastritis and peptic ulcer].
    Schütz E; Stolte M
    Leber Magen Darm; 1994 Jul; 24(4):147-9. PubMed ID: 7934607
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Helicobacter pylori-positive peptic ulcer disease.
    Malfertheiner P
    Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
    [No Abstract]   [Full Text] [Related]  

  • 10. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].
    Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu
    Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.
    Ford AC; Delaney BC; Forman D; Moayyedi P
    Am J Gastroenterol; 2004 Sep; 99(9):1833-55. PubMed ID: 15330927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
    Tsuji S; Kawano S
    J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Helicobacter pylori infection.
    Ebell MH
    J Fam Pract; 1996 Jun; 42(6):568. PubMed ID: 8656165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
    Grinevich VB; Sablin OA; Gubonina IV; Dobrenko VA
    Eksp Klin Gastroenterol; 2005; (2):95-9. PubMed ID: 15932163
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Helicobacter pylori positive ulcer--the search for simple and effective therapy].
    Eliakim R; Rachmileweitz D
    Harefuah; 1996 Nov; 131(10):405-6. PubMed ID: 8981820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.